NEWS RELEASES
2024
2023
USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024
Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers”
USMI Receives FDA Approval for New Robotic Surgery Device – The Canady Flex RoboWrist™
JCRI-ABTS and USMI Reports Statistically Significant Results of the Canady Helios Cold Plasma Phase 1 Clinical Trial on Patients with Stage 4 and Recurrent Advanced Solid Tumors
2022
2022 US Medical Innovations Raises $10.2 M in Private Placement
JCRI – ABTS and USMI to Present a Two-year Follow-up of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at Israeli Society of Surgical Oncology
JCRI DISCOVERS REGULATORY GENE BCL2A1 FOR TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
2021
USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases
USMI to Announce Successful Results of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare Conference
JCRI Discovers the Mechanism using Canady Helios™ Cold Plasma to Induce Cell Death in Breast Cancer
USMI Developing the First Surgical Robot for Cancer Surgery
JCRI-ABTS and USMI Successfully Use Canady Helios™ Cold Plasma in Combination with FOLFIRINOX for the Treatment of Cholangiocarcinoma
JCRI-ABTS and USMI Successfully Complete Phase 1 Multi-Center Clinical Trial Using Canady Helios™ Cold Plasma for the Treatment of Cancer
2020
Rush Cancer Surgeons Perform Country’s First Cold Plasma Adjuvant Therapy
Canady Cold Atmospheric Plasma Provides New Insight for the Potential Treatment of Breast Cancer
JCRI-ABTS Seeks FDA Emergency Use Authorization for the Canady Helios Cold Plasma HERO System for the Treatment of COVID-19
Canady Helios Cold Plasma Scalpel Successfully Used by Chaim Sheba Medical Center Surgeons to Remove Inoperable Retroperitoneal Cancer
2019
US Medical Innovations Receives FDA 510(k) Clearance for the Canady Plasma Smart XL-1000 Generator
US Medical Innovations to Present at the Baird 2019 Global Healthcare Conference
USMI and JCRI-ABTS Receive FDA Approval to Conduct the First U.S. Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Cancer
Canady Life Sciences Acquires French Robotic Surgical Company Endocontrol and its Voice-Operated Robotic Technology
US Medical Innovations to Present at the JMP Securities Life Sciences Conference
2018
US Medical Innovations to Present Canady Robotics SR-70™ Surgical System, the First Mini-Invasive Robotic Assisted Surgical System That Fits in the Palm of Your Hand, at the 2018 American College of Surgeons Clinical Congress
Jerome Canady, M.D. Invited Speaker: The Evolution of Plasma Energy ACS Session: Energy Sources in Surgery: How to Improve Efficacy Congresso Congiunto 2018 Society of Italian Surgeons
US Patent Office Issues Decision to Grant Patent for USMI’s Cold Atmospheric Plasma for the Selective Ablation of Cancer Cells
US Patent Office Issues Patent for USMI’s Cold Atmospheric Plasma for the Treatment of Cancer
2017
Presenting the new Canady Robotic™ Surgical System and the Canady Plasma® Smart Electrosurgical Generator. Visit us in Booth #1431 at the 2017 ACS Clinical Congress in San Diego, CA at the San Diego Convention Center from October 23rd – 25th 2017
US Medical Innovations, LLC and the George Washington University Sign a $5.3 Million Agreement to Launch a New Plasma-Based Cancer Therapy Program
GW Signs $5.3 Million Agreement to Research Plasma-Based Cancer Therapies
US Medical Innovations Announces Canady Helios Cold Plasma and Hybrid Plasma Scalpels Used in the First Clinical Liver Resection Performed to Remove and Selectively Kill Liver Cancer Tumor Cells
2016
Chinese Patent Office Issues Decision to Grant Patent for USMI’s Canady Hybrid Plasma™ Technology
Japanese Patent Office Issues Decision to Grant Patent for USMI’s Canady Hybrid Plasma™ Technology
US Medical Innovations, LLC receives ISO 13485:2003 Certification following review of the Quality Management System for USMI, PMLS, Canady Robotics and Canady Biotechnology.
2015
US Medical Innovations Announces Plans for New Robotic Surgical System
USMI receives Federal Supply Schedule Contract Approval.
Cold Plasma Used In World’s First Clinical Surgical Procedure Performed To Selectively Kill Cancer Tumor Cells
Dr. Jerome Canady on Bloodless Surgery & Being a Pioneer – The Global Townhall Interview
US Patent Innovations, LLC announces Jerome Canady Research Institute receives ISO-9001: 2008 Certification
2014
US Medical Innovations, LLC Announces New Distribution Agreement With CrossLink Surgical, LLC
US Patent Innovations, LLC Opens State-Of-The-Art Scientific Research Facility To Advance Uses Of Plasma Technology And Techniques In Medicine
US Medical Innovations, LLC Introduces New Canady Hybrid Plasma™ Scalpel
2013
US Medical Innovations, LLC Announces Distribution Agreement with Chesapeake Surgical
Temple University Surgeons Successfully Remove Inoperable Metastatic Breast Cancer with the Canady Vieira Hybrid Plasma Scalpel
GAO Dismisses Request for Reconsideration by ERBE Contractor, Supporting Previous Ruling in Favor of Bidder Offering US Medical Innovations, LLC’s Product
US Patent Innovations, LLC Completes Plasma Technology Research Agreement with The George Washington University
GAO Sustains Protest by Bidder Offering US Medical Innovations, LLC’s Product Against Federal Purchase of ERBE Product
2012
US Medical Innovations, LLC Parent Company Signs Technology Transfer Agreement with George Washington University and Johns Hopkins University on Cold Plasma
View Full Release
US Medical Innovations, LLC Announces Global Agreements with WEM Equipamentos Electrônicos LTDA for Development, Manufacturing and Distribution
View Full Release